Non-targeted metabolomic analysis of Xueshuantong injection in patients with STEMI
- 18 August 2025
- journal article
- Published by Elsevier in Fitoterapia
- Vol. 186, 106802
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Traditional Chinese Medicine Compound (Tongxinluo) and Clinical Outcomes of Patients With Acute Myocardial InfarctionJAMA, 2023
- Inhibition of the Ras/ERK1/2 pathway contributes to the protective effect of ginsenoside Re against intimal hyperplasiaFood & Function, 2021
- Cardioprotection of Panax Notoginseng saponins against acute myocardial infarction and heart failure through inducing autophagyBiomedicine & Pharmacotherapy, 2021
- Panax Notoginseng Saponins Inhibits Ventricular Remodeling after Myocardial Infarction in Rats Through Regulating ATF3/MAP2K3/p38 MAPK and NF κ B PathwayChinese Journal of Integrative Medicine, 2020
- CB-Dock: a web server for cavity detection-guided protein–ligand blind dockingActa Pharmacologica Sinica, 2019
- Panax Notoginseng Saponins Attenuate Myocardial Ischemia-Reperfusion Injury Through the HIF-1α/BNIP3 Pathway of AutophagyJournal of Cardiovascular Pharmacology, 2019
- UHPLC–Q‐TOF‐MS‐based metabolomics approach to compare the saponin compositions of Xueshuantong injection and Xuesaitong injectionJournal of Separation Science, 2017
- Method development and application of offline two-dimensional liquid chromatography/quadrupole time-of-flight mass spectrometry-fast data directed analysis for comprehensive characterization of the saponins from Xueshuantong InjectionJournal of Pharmaceutical and Biomedical Analysis, 2016
- Amelioration of acute myocardial infarction by saponins from flower buds of Panax notoginseng via pro-angiogenesis and anti-apoptosisJournal of Ethnopharmacology, 2016
- Retrospective analysis of thrombolysis therapy for 64 cases of acute myocardial infarction with elevated ST segmentChinese Journal of Integrative Medicine, 2009